Market Cap 97.49M
Revenue (ttm) 28.70M
Net Income (ttm) -66.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -233.28%
Debt to Equity Ratio 0.00
Volume 11,568,300
Avg Vol 5,416,006
Day's Range N/A - N/A
Shares Out 228.31M
Stochastic %K 7%
Beta 1.14
Analysts Strong Sell
Price Target $4.67

Company Profile

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influ...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 550 3500
Fax: 650 871 8580
Website: vaxart.com
Address:
170 Harbor Way, Suite 300, South San Francisco, United States
ndouglas48
ndouglas48 Jul. 30 at 9:43 PM
$VXRT hate to say it friends, but we need a close above $0.45 tomorrow to still be able to state a reversal has happened and the bottom is in. If it doesn’t happen I would expect to retest our previous bottom in the coming weeks/months… a close above $0.40 would still be a positive sign but $0.45 would be much more validating… guess we will see.
0 · Reply
Vax87
Vax87 Jul. 30 at 9:36 PM
$VXRT What happened to David Scott?
0 · Reply
Vaxylove
Vaxylove Jul. 30 at 9:27 PM
$VXRT Rise Up Here’s the reasons for adding paper ballots, all advantages for Vaxart: 1. Reach shareholders who didn’t vote. 2. Allows companies to include advocacy materials in their proxy mailings. This is huge, since shareholders will not see the retail perspective. 3. Paper ballots create a physical audit trail. This can be used to prove procedural fairness. 4. Vote dilution or confusion: Paper ballots can delay voting clarity, especially if they’re returned close to the meeting date. This can create confusion about vote tallies or make it harder for shareholders to coordinate. 5. Overwhelm the system: If Vaxart anticipates close results or legal resistance, introducing another layer (paper) can create logistical noise that benefits them — especially if they control the tabulation process closely. 6. Offset highly engaged anti-RS retail voters. 7. Boost "default yes" votes from disengaged holders. 8. Stall or obscure fast-moving online vote counts until the final tally. Paper ballots (or digital proxies) can include: • Letters from the CEO or board encouraging a YES vote • Q&A sections or graphics explaining why the RS is needed • Risk warnings if the proposal is not approved (e.g., delisting) JJ: Historically, what is the percentage of additional votes tabulated by adding paper ballots? A: "When paper proxy materials are mailed, retail participation can increase by 5–15 percentage points. Some studies show up to a 30–40% increase in relative turnout. Broadridge Financial Solutions, which handles many proxy votes, has published data showing "full set” mailings (including paper ballots) boost participation — especially among older or less tech-savvy investors. According to a 2018 SEC report on proxy process reform, physical mailings were found to increase voting by 6–10% among certain shareholder segments." _________________________ There isn’t ONE WORD in the 8K filing about brokers who don’t support votes OTC. This seems like a huge material omission. I asked chat: “Given Vaxart is currently suspended, but may be delisted, and the potential impact of this event on shareholders who own through brokers who do not support delisted companies, could Vaxart have committed SEC violations by not providing shareholders this information?” ✅ Yes, because: 1. Voting rights are fundamental to shareholder value and governance. 2. Losing access to your shares or vote due to broker limitations is not a technicality — it could swing the vote outcome. 3. The timing is not coincidental: delisting before a controversial vote could disenfranchise a known group (retail holders). 4. If Vaxart knows this is a likely risk and fails to disclose it, that could be seen as a material omission under Rule 14a-9 (SEC anti-fraud rule for proxy solicitations). 5. Adding paper proxy ballots for the first time in Vaxart’s 4th reverse split (RS) vote might raise eyebrows. SEC Rule 14a-9: “No solicitation shall be made by means of any proxy statement ... containing any statement which ... omits to state any material fact necessary in order to make the statements therein not false or misleading.” In this case, failing to tell shareholders they might not be able to vote because of delisting-related broker issues — despite having set the vote after the potential delisting — could be seen as misleading and a violation of SEC disclosure rules. *The key issue is intentional or negligent omission of information that would affect a shareholder’s decision or ability to participate. *This is especially concerning given this is their 4th attempt at a reverse split, and retail opposition is well-documented. JJ: Btw, what if shareholders using brokers who don’t support companies traded OTC vote against the reverse split before Vaxart is actually delisted? Once delisted, with their votes still count? Chat: Yes. JJ: They’re pulling out all the stops. This is wearing some of us down. I see posts where folks are tired of all the BS and don’t want to contact the media or the SEC. How will these folks feel when they lose 95% of their shares? We don’t need a reverse split. We have sentinel data coming. And Avian going into P1. And possible Avian funding. And Noro P2 is supposed to start the second half of this year. Even if it starts by EOY, we’ll have 60-day data by March. And the possibility of Gates re-upping on second gen Noro breastfeeding trial. P2 valuations are 2-10x higher than P1. This is the final countdown. We either lose up to 95% of our shares or we don’t. This is no time to get complacent. Last week, I posted that we had the votes, but we could now be the underdog, as they now have several advantages this time around. We need to be even more proactive than before. Like I said the other day, I’ve never had to work so hard to keep what’s already mine. This is the time to stand up. I’m fighting like hell. Who’s with me?
7 · Reply
Chalutz
Chalutz Jul. 30 at 9:27 PM
$VXRT Why hasn't HARPUA BEEN BLOCKED FROM HERE. HE‘S OBVIOUSLY A FN PAID TROLL? IF HE WASN’T A TROLL HE WOULDN‘T BE ASKING OTHERS FOR QUESTIONS?
1 · Reply
Karol98
Karol98 Jul. 30 at 9:20 PM
$VXRT Fuck it. Time to screw those motherfuckers one last time before we’re gone.
0 · Reply
TrendSetter67
TrendSetter67 Jul. 30 at 9:09 PM
$VXRT If the earnings does not have some positive news on funding/partnership, those below .20 OTC prices might be seen as the BARDA PNG funds only slow their overall cash burn. And cash continues to be king in market valuation.
1 · Reply
vigi
vigi Jul. 30 at 8:56 PM
$VXRT same old story...same old story...same old song and dance. https://www.yahoo.com/news/articles/susan-monarez-confirmed-cdc-director-001618580.html
0 · Reply
WALTERPAYTON34
WALTERPAYTON34 Jul. 30 at 8:45 PM
$VXRT stay focused JJ DONT LET THESE JAGS GET TO YOU
0 · Reply
Terry_CA3
Terry_CA3 Jul. 30 at 8:44 PM
$VXRT https://www.youtube.com/live/67ywPMioVYg?si=8rzXC6V35b9izKeq
1 · Reply
Harpua97
Harpua97 Jul. 30 at 8:32 PM
$VXRT Great idea, @Edpolo. Rather than just fighting amongst ourselves, how about we build out a list of key questions to present to Lo during the fireside chat? We should be professional and respectful, but should also hold his feet to the fire for clear answers to important questions. Here are mine: - Can you provide the rationale for why preferred shares aren’t being reduced, and definitive assurances of how the preferred shares will or will not be used? - If retail should approve an r/s, will you offer any assurances of no dilution (with the exception of if needed for a partnership/acquisition) for at least a certain amount of time to see if we can get some SP momentum? - Will the BOD put some more skin in the game by committing to tie a greater portion of compensation to share price if r/s is approved? - 1:5 - 1:20 is still a fairly wide range. What is ultimately going in to the determination of the ratio, and can you provide a target post-r/s share price so we can better gauge what ratio to expect? - Why haven’t we seen additional market buys by the BOD at these bargain prices? - Have partnership talks progressed in any meaningful way since first being discussed months ago? - Are you still forecasting Noro P2 to begin in 2025, and is that fully contingent on sealing a partnership deal? - When can we expect updated efficacy data on the sentinel 400? - Why do you think the share price has been held down, and what are your plans to improve it? - Has the company continued to look into naked shorting and other potential manipulation by institutional traders? If so, what have you found? If not, why? What else am I missing? Again, not the conspiracy stuff or accusations of criminality. I expect that those wont be taken seriously, because they aren’t serious questions. But that doesn’t mean we can’t ask tough (yet reasonable) questions.
5 · Reply
Latest News on VXRT
Vaxart Announces Adjournment of Annual Meeting of Stockholders

Jun 2, 2025, 4:20 PM EDT - 2 months ago

Vaxart Announces Adjournment of Annual Meeting of Stockholders


Vaxart, Inc. (VXRT) Q1 2025 Earnings Call Transcript

May 13, 2025, 8:43 PM EDT - 2 months ago

Vaxart, Inc. (VXRT) Q1 2025 Earnings Call Transcript


Vaxart Appoints Jeroen Grasman as Chief Financial Officer

May 13, 2025, 4:01 PM EDT - 2 months ago

Vaxart Appoints Jeroen Grasman as Chief Financial Officer


Vaxart, Inc. (VXRT) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 6:25 PM EDT - 4 months ago

Vaxart, Inc. (VXRT) Q4 2024 Earnings Call Transcript


Vaxart, Inc. (VXRT) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 6:19 PM EST - 9 months ago

Vaxart, Inc. (VXRT) Q3 2024 Earnings Call Transcript


Vaxart, Inc. (VXRT) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 8:51 PM EDT - 1 year ago

Vaxart, Inc. (VXRT) Q2 2024 Earnings Call Transcript


Vaxart Provides Business Update

Jun 17, 2024, 4:05 PM EDT - 1 year ago

Vaxart Provides Business Update


Vaxart, Inc. (VXRT) Q1 2024 Earnings Call Transcript

May 13, 2024, 5:49 PM EDT - 1 year ago

Vaxart, Inc. (VXRT) Q1 2024 Earnings Call Transcript


Vaxart, Inc. (VXRT) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 7:03 PM EDT - 1 year ago

Vaxart, Inc. (VXRT) Q4 2023 Earnings Call Transcript


ndouglas48
ndouglas48 Jul. 30 at 9:43 PM
$VXRT hate to say it friends, but we need a close above $0.45 tomorrow to still be able to state a reversal has happened and the bottom is in. If it doesn’t happen I would expect to retest our previous bottom in the coming weeks/months… a close above $0.40 would still be a positive sign but $0.45 would be much more validating… guess we will see.
0 · Reply
Vax87
Vax87 Jul. 30 at 9:36 PM
$VXRT What happened to David Scott?
0 · Reply
Vaxylove
Vaxylove Jul. 30 at 9:27 PM
$VXRT Rise Up Here’s the reasons for adding paper ballots, all advantages for Vaxart: 1. Reach shareholders who didn’t vote. 2. Allows companies to include advocacy materials in their proxy mailings. This is huge, since shareholders will not see the retail perspective. 3. Paper ballots create a physical audit trail. This can be used to prove procedural fairness. 4. Vote dilution or confusion: Paper ballots can delay voting clarity, especially if they’re returned close to the meeting date. This can create confusion about vote tallies or make it harder for shareholders to coordinate. 5. Overwhelm the system: If Vaxart anticipates close results or legal resistance, introducing another layer (paper) can create logistical noise that benefits them — especially if they control the tabulation process closely. 6. Offset highly engaged anti-RS retail voters. 7. Boost "default yes" votes from disengaged holders. 8. Stall or obscure fast-moving online vote counts until the final tally. Paper ballots (or digital proxies) can include: • Letters from the CEO or board encouraging a YES vote • Q&A sections or graphics explaining why the RS is needed • Risk warnings if the proposal is not approved (e.g., delisting) JJ: Historically, what is the percentage of additional votes tabulated by adding paper ballots? A: "When paper proxy materials are mailed, retail participation can increase by 5–15 percentage points. Some studies show up to a 30–40% increase in relative turnout. Broadridge Financial Solutions, which handles many proxy votes, has published data showing "full set” mailings (including paper ballots) boost participation — especially among older or less tech-savvy investors. According to a 2018 SEC report on proxy process reform, physical mailings were found to increase voting by 6–10% among certain shareholder segments." _________________________ There isn’t ONE WORD in the 8K filing about brokers who don’t support votes OTC. This seems like a huge material omission. I asked chat: “Given Vaxart is currently suspended, but may be delisted, and the potential impact of this event on shareholders who own through brokers who do not support delisted companies, could Vaxart have committed SEC violations by not providing shareholders this information?” ✅ Yes, because: 1. Voting rights are fundamental to shareholder value and governance. 2. Losing access to your shares or vote due to broker limitations is not a technicality — it could swing the vote outcome. 3. The timing is not coincidental: delisting before a controversial vote could disenfranchise a known group (retail holders). 4. If Vaxart knows this is a likely risk and fails to disclose it, that could be seen as a material omission under Rule 14a-9 (SEC anti-fraud rule for proxy solicitations). 5. Adding paper proxy ballots for the first time in Vaxart’s 4th reverse split (RS) vote might raise eyebrows. SEC Rule 14a-9: “No solicitation shall be made by means of any proxy statement ... containing any statement which ... omits to state any material fact necessary in order to make the statements therein not false or misleading.” In this case, failing to tell shareholders they might not be able to vote because of delisting-related broker issues — despite having set the vote after the potential delisting — could be seen as misleading and a violation of SEC disclosure rules. *The key issue is intentional or negligent omission of information that would affect a shareholder’s decision or ability to participate. *This is especially concerning given this is their 4th attempt at a reverse split, and retail opposition is well-documented. JJ: Btw, what if shareholders using brokers who don’t support companies traded OTC vote against the reverse split before Vaxart is actually delisted? Once delisted, with their votes still count? Chat: Yes. JJ: They’re pulling out all the stops. This is wearing some of us down. I see posts where folks are tired of all the BS and don’t want to contact the media or the SEC. How will these folks feel when they lose 95% of their shares? We don’t need a reverse split. We have sentinel data coming. And Avian going into P1. And possible Avian funding. And Noro P2 is supposed to start the second half of this year. Even if it starts by EOY, we’ll have 60-day data by March. And the possibility of Gates re-upping on second gen Noro breastfeeding trial. P2 valuations are 2-10x higher than P1. This is the final countdown. We either lose up to 95% of our shares or we don’t. This is no time to get complacent. Last week, I posted that we had the votes, but we could now be the underdog, as they now have several advantages this time around. We need to be even more proactive than before. Like I said the other day, I’ve never had to work so hard to keep what’s already mine. This is the time to stand up. I’m fighting like hell. Who’s with me?
7 · Reply
Chalutz
Chalutz Jul. 30 at 9:27 PM
$VXRT Why hasn't HARPUA BEEN BLOCKED FROM HERE. HE‘S OBVIOUSLY A FN PAID TROLL? IF HE WASN’T A TROLL HE WOULDN‘T BE ASKING OTHERS FOR QUESTIONS?
1 · Reply
Karol98
Karol98 Jul. 30 at 9:20 PM
$VXRT Fuck it. Time to screw those motherfuckers one last time before we’re gone.
0 · Reply
TrendSetter67
TrendSetter67 Jul. 30 at 9:09 PM
$VXRT If the earnings does not have some positive news on funding/partnership, those below .20 OTC prices might be seen as the BARDA PNG funds only slow their overall cash burn. And cash continues to be king in market valuation.
1 · Reply
vigi
vigi Jul. 30 at 8:56 PM
$VXRT same old story...same old story...same old song and dance. https://www.yahoo.com/news/articles/susan-monarez-confirmed-cdc-director-001618580.html
0 · Reply
WALTERPAYTON34
WALTERPAYTON34 Jul. 30 at 8:45 PM
$VXRT stay focused JJ DONT LET THESE JAGS GET TO YOU
0 · Reply
Terry_CA3
Terry_CA3 Jul. 30 at 8:44 PM
$VXRT https://www.youtube.com/live/67ywPMioVYg?si=8rzXC6V35b9izKeq
1 · Reply
Harpua97
Harpua97 Jul. 30 at 8:32 PM
$VXRT Great idea, @Edpolo. Rather than just fighting amongst ourselves, how about we build out a list of key questions to present to Lo during the fireside chat? We should be professional and respectful, but should also hold his feet to the fire for clear answers to important questions. Here are mine: - Can you provide the rationale for why preferred shares aren’t being reduced, and definitive assurances of how the preferred shares will or will not be used? - If retail should approve an r/s, will you offer any assurances of no dilution (with the exception of if needed for a partnership/acquisition) for at least a certain amount of time to see if we can get some SP momentum? - Will the BOD put some more skin in the game by committing to tie a greater portion of compensation to share price if r/s is approved? - 1:5 - 1:20 is still a fairly wide range. What is ultimately going in to the determination of the ratio, and can you provide a target post-r/s share price so we can better gauge what ratio to expect? - Why haven’t we seen additional market buys by the BOD at these bargain prices? - Have partnership talks progressed in any meaningful way since first being discussed months ago? - Are you still forecasting Noro P2 to begin in 2025, and is that fully contingent on sealing a partnership deal? - When can we expect updated efficacy data on the sentinel 400? - Why do you think the share price has been held down, and what are your plans to improve it? - Has the company continued to look into naked shorting and other potential manipulation by institutional traders? If so, what have you found? If not, why? What else am I missing? Again, not the conspiracy stuff or accusations of criminality. I expect that those wont be taken seriously, because they aren’t serious questions. But that doesn’t mean we can’t ask tough (yet reasonable) questions.
5 · Reply
Vax87
Vax87 Jul. 30 at 8:24 PM
$VXRT The 10s man strikes again, lowering the share price by over 3% with the last trade of the day. This is being done almost every single day without fail, and someone is doing it with $40-$300. It fits the narrative. Outside unforeseen forces want Vaxart lower Lo wants Vaxart lower BOD wants Vaxart lower Well, let us ask the BIG QUESTION: If Vaxart is a FUND, who benefits if the share price goes up, and more importantly, who LOSES money somehow? Sounds like a simple question, and it may have simple answers, or there is more to it. This is hyper manipulation to the extreme. Why? Has everyone forgotten about phase II for Noro(article last week) or the 400 Data, or the next steps for the Covid trial? The whole narrative is share price manipulation down, without taking one break. And, the company, illegally, aiding this narrative, even though their HF is doing it. WHY?
1 · Reply
Edpolo
Edpolo Jul. 30 at 8:03 PM
$VXRT -228M Common Shares -117M Authorized Shared (unissued) - 5M Preferred Shares (unissued) If i own 3.5M share of Common Shares, i would be owning 1% of the Float What the RS ratio is, i would want to safeguard that 1% post R/S. This is what the majority of SH want. If NASDAQ Compliance is THE Main Concern to secure liquidity and easy access to funding, The BOD would be required to revise the proxy along those guidelines (i.e. Preserve the % of retail ownership post R/S, individually and collectively). This is THE ELEPHANT in the room, in addition to defining the privileges of the Preferred Shares (voting powers, voting rights and restrictions on usage). This should be the baseline of ANY future proxy (besides, Strategy / Planning / Milestones /Timelines /Funding /Partnership) as i don’t think the current one will more successful than its predecessors. It’ll be a NO VOTE by more than 100M votes GLTA
1 · Reply
paperblood
paperblood Jul. 30 at 8:02 PM
$VXRT Next is 0.25 or 0.50? VXRT Clown management at his BEST!
0 · Reply
Vax87
Vax87 Jul. 30 at 7:54 PM
$VXRT Call me crazy - there is still a gap at .81. ALL other gaps have ben filled. ALL. It will be filled sooner than later too.
1 · Reply
Vaxylove
Vaxylove Jul. 30 at 7:54 PM
$VXRT Hey folks, I’ve absolutely had it with this Board. I’ll be posting later today, and you’ll see why.
4 · Reply
vigi
vigi Jul. 30 at 7:54 PM
$VXRT UPS ?
0 · Reply
vigi
vigi Jul. 30 at 7:49 PM
$VXRT our ding dong management and BODs business plan ..."VALUE DESTRUCTION"... when handcuffs ?
0 · Reply
Tycho11261
Tycho11261 Jul. 30 at 7:49 PM
$VXRT don't like the share price? Couldn't be Steve's fault! This paid cum rag of a media outlet says he's GREAT!😂
0 · Reply
Vax87
Vax87 Jul. 30 at 7:44 PM
$VXRT 20M shares covered in the .30s and raised the share price to .46. Volume stops, and people try shorting this straight down on low volume. Meanwhile, back at the ranch, LO comes up with a new black cloud. It is NOT by coincidence, yet again. Perfect timing on the heels of the first tranche of a massive short cover. Translation, they ARE NOT DONE COVERING. Notice how patient the A-holes were. 15 Straight days down to close out nasdaq. Read that again. And then, they fooled with the price here on OTC on low volume to try to get it even lower, before they covered with 20M+ shares. AND, the pigs covered millions of shares, somehow, in block trades afterhours so they did not raise the PRICE!!! THEY ASKED LO FOR SOME MORE TIME, HENCEFORTH, THE BS RS, AND LOW AND BEHOLD, WE ARE BACK IN THE .30s. THEY ARE NOT DONE COVERING. If retail pushed this over .50 very quickly, we would see .70, very quickly, and maybe higher. They have to cover, MORE
3 · Reply
vxrtloktar2019
vxrtloktar2019 Jul. 30 at 7:41 PM
$VXRT 500m funding paused, reinstated, and never spoken about again by RFK jr... clown world
0 · Reply
LuckyLee
LuckyLee Jul. 30 at 7:35 PM
$VXRT Why in God Name isn't the SEC prosecuting and jailing Vaxart CEO Steve Lo and BOD's Chairman Finney and anyone else on the BOD's that involved with the Stock manuplation to make themselves Rich at the Retail stock owners expense???
0 · Reply
Garza759ify_YF
Garza759ify_YF Jul. 30 at 7:33 PM
$VXRT VXRT management’s main mission is highway robbery of VXRT investors all shares.
0 · Reply